HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jae-Hoon Chang Selected Research
Jae-Hoon Chang Research Topics
Disease
15
Neoplasms (Cancer)
03/2024 - 01/2018
8
Inflammation (Inflammations)
01/2022 - 08/2011
6
Colitis
01/2023 - 07/2014
6
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 09/2010
4
Anaphylaxis (Anaphylactic Shock)
09/2019 - 01/2017
4
Autoimmune Diseases (Autoimmune Disease)
01/2018 - 09/2010
3
Disease Progression
02/2017 - 01/2017
2
Breast Neoplasms (Breast Cancer)
09/2023 - 03/2020
2
Hyperplasia
02/2013 - 06/2010
1
Lung Neoplasms (Lung Cancer)
03/2024
1
Triple Negative Breast Neoplasms
01/2023
1
Adenocarcinoma
10/2021
1
Hypoxia (Hypoxemia)
01/2021
1
Infections
01/2021
1
Mitochondrial Diseases (Mitochondrial Disease)
12/2018
1
Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2018
1
Necrosis
01/2018
1
Multiple Sclerosis
01/2018
1
Ulcerative Colitis
01/2018
1
Insulin Resistance
01/2018
1
Hypersensitivity (Allergy)
01/2017
1
Neuroinflammatory Diseases
01/2015
1
Immune System Diseases (Immune Disorders)
10/2014
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2014
1
Edema (Dropsy)
07/2014
Drug/Important Bio-Agent (IBA)
5
Proteins (Proteins, Gene)
FDA Link
03/2024 - 07/2004
4
Dextran Sulfate
IBA
01/2021 - 01/2018
3
Reactive Oxygen Species (Oxygen Radicals)
IBA
09/2023 - 12/2018
3
Cytokines
IBA
12/2022 - 07/2014
3
Sirtuin 1
IBA
01/2022 - 01/2017
3
Antigens
IBA
01/2021 - 02/2013
2
Antibodies
IBA
03/2024 - 12/2022
2
Interferon Type I
IBA
09/2023 - 01/2023
2
Vaccines
IBA
09/2023 - 10/2014
2
Chemokines
IBA
01/2023 - 10/2019
2
Inflammasomes
IBA
01/2023 - 03/2020
2
AMP-Activated Protein Kinases
IBA
01/2022 - 01/2017
2
Ligands
IBA
08/2021 - 10/2019
2
Mevalonic Acid (Mevalonate)
IBA
01/2021 - 01/2019
2
Interleukin-2 (IL2)
IBA
01/2021 - 10/2019
2
Anti-Allergic Agents (Antiallergic Agents)
IBA
01/2018 - 01/2017
2
Interleukin-17 (Interleukin 17)
IBA
01/2018 - 01/2017
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2024
1
Messenger RNA (mRNA)
IBA
03/2024
1
Bevacizumab (Avastin)
FDA Link
03/2024
1
Peptides (Polypeptides)
IBA
09/2023
1
HMGB1 Protein (HMG1)
IBA
09/2023
1
Calreticulin
IBA
09/2023
1
LTX-315
IBA
09/2023
1
Methionine (L-Methionine)
FDA Link
01/2023
1
S-Adenosylmethionine (Ademetionine)
IBA
01/2023
1
Programmed Cell Death 1 Receptor
IBA
01/2023
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2023
1
Neoplasm Antigens (Tumor Antigens)
IBA
12/2022
1
Polylactic Acid-Polyglycolic Acid Copolymer
IBA
12/2022
1
Ribonucleotides
IBA
01/2022
1
AICA ribonucleotide (ZMP)
IBA
01/2022
1
maleimide
IBA
12/2021
1
Acids
IBA
12/2021
1
Gemcitabine
FDA Link
10/2021
1
serotonin 7 receptor
IBA
10/2021
1
Albumins
IBA
08/2021
1
geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)
IBA
01/2021
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2021
1
Cholesterol
IBA
01/2021
1
Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)
IBA
01/2021
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2021
1
Simvastatin (Zocor)
FDA Link
Generic
01/2021
1
TNF Receptor-Associated Factor 2 (TRAF2)
IBA
01/2021
1
Adipokines
IBA
03/2020
1
NLR Proteins
IBA
03/2020
1
Adiponectin
IBA
03/2020
1
Interleukin-10 (Interleukin 10)
IBA
01/2020
1
Tacrolimus (Prograf)
FDA Link
Generic
12/2019
1
Polymers
IBA
12/2019
1
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2019
1
MicroRNAs (MicroRNA)
IBA
12/2019
1
Folic Acid (Vitamin M)
FDA Link
Generic
12/2019
1
Imiquimod (Aldara)
FDA Link
Generic
10/2019
1
Liposomes (Liposome)
IBA
10/2019
1
sauchinone
IBA
09/2019
1
Orphan Nuclear Receptors
IBA
01/2019
1
Member 1 Group A Nuclear Receptor Subfamily 4
IBA
01/2019
1
Arachidonic Acid (Vitamin F)
IBA
12/2018
1
Ionophores
IBA
12/2018
1
salinomycin
IBA
12/2018
1
tanshinone
IBA
01/2018
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2018
1
2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindolium
IBA
01/2018
1
BJ-1108
IBA
02/2017
1
Non-Receptor Type 1 Protein Tyrosine Phosphatase
IBA
01/2017
1
Resveratrol
IBA
01/2017
1
BJ-2266
IBA
01/2017
1
BJ-3105
IBA
01/2017
1
Interferons
IBA
01/2017
1
Phosphotransferases (Kinase)
IBA
01/2015
Therapy/Procedure
6
Immunotherapy
09/2023 - 01/2018
5
Therapeutics
03/2024 - 01/2018
1
Drug Therapy (Chemotherapy)
08/2021
1
Microspheres (Microsphere)
12/2019